NeoGenomics names Warren Stone CEO effective Jan. 4, 2027

Bitget2026/10/05 20:07

NeoGenomics named President and COO Warren Stone as CEO and a board member, effective Jan. 4, 2027. Stone, 54, previously held senior roles at Ortho Clinical Diagnostics and MilliporeSigma/Merck KGaA; he joined NeoGenomics in 2022. Board Chair Lynn Tetrault will step down as chair on Jan. 4, 2027, then exit the board at the 2027 annual meeting. Independent director Michael Kelly will become lead independent director on Jan. 4, 2027. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. NeoGenomics Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 202610051605BIZWIRE_USPR_____20261005_BW134566) on October 05, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

You may also like

Zymeworks Publishes Update to Financial Calendar

Bitget•2026/10/15 10:00

KWAP cuts stake in Velesto Energy to 5.646%

Bitget•2026/10/15 09:50

Australia Tests Cross-Border Settlements Using Tokenized Deposits

Coinspaidmedia•2026/10/15 09:39

An exchange: Bitcoin long-term holders have floating profits of about 64%, while recent buyers only have floating profits of 9%.

BlockBeats•2026/10/15 09:33